Soluble RAGE in type 2 diabetes: Association with oxidative stress

Eleonora Devangelio, Francesca Santilli, Gloria Formoso, Patrizia Ferroni, Loredana Bucciarelli, Noemi Michetti, Cristina Clissa, Giovanni Ciabattoni, Agostino Consoli, Giovanni Davì

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

Advanced glycation end products (AGEs) contribute to diabetic vascular complications by engaging the AGE receptor (RAGE). A soluble RAGE form (sRAGE) acts as a decoy domain receptor, thus decreasing AGE cellular binding. A cross-sectional comparison of sRAGE, asymmetric dimethylarginine (ADMA) plasma levels (index of endothelial dysfunction), and urinary 8-iso-prostaglandin (PG)F (marker of oxidative stress) was performed between 86 diabetic patients and 43 controls. Plasma sRAGE levels were significantly lower and ADMA levels were significantly higher in diabetic patients as compared to controls (P <0.0001). HbA1c and urinary 8-iso-PGF were correlated inversely with sRAGE and directly with ADMA. On multivariate analysis HbA1c was independently related to sRAGE levels in diabetic patients. Twenty-four of 86 patients with newly diagnosed diabetes and 12 patients in poor metabolic control were reevaluated after treatment with a hypoglycemic agent or insulin, respectively. Improvement in metabolic control by oral agents or insulin resulted in a significant increase in sRAGE and decrease in ADMA levels (P <0.0001). Thus, poor glycemic control reduces sRAGE levels, in association with enhanced oxidative stress and endothelial dysfunction in diabetes. These abnormalities are susceptible to modulation by improvement in metabolic control.

Original languageEnglish
Pages (from-to)511-518
Number of pages8
JournalFree Radical Biology and Medicine
Volume43
Issue number4
DOIs
Publication statusPublished - Aug 15 2007

Fingerprint

Oxidative stress
Medical problems
Type 2 Diabetes Mellitus
Oxidative Stress
Dinoprost
Insulin
Diabetic Angiopathies
Advanced Glycosylation End Products
Plasmas
Hypoglycemic Agents
Multivariate Analysis
Modulation
Association reactions
N,N-dimethylarginine

Keywords

  • ADMA
  • Oxidative stress
  • RAGE
  • Type 2 diabetes

ASJC Scopus subject areas

  • Medicine(all)
  • Toxicology
  • Clinical Biochemistry

Cite this

Soluble RAGE in type 2 diabetes : Association with oxidative stress. / Devangelio, Eleonora; Santilli, Francesca; Formoso, Gloria; Ferroni, Patrizia; Bucciarelli, Loredana; Michetti, Noemi; Clissa, Cristina; Ciabattoni, Giovanni; Consoli, Agostino; Davì, Giovanni.

In: Free Radical Biology and Medicine, Vol. 43, No. 4, 15.08.2007, p. 511-518.

Research output: Contribution to journalArticle

Devangelio, E, Santilli, F, Formoso, G, Ferroni, P, Bucciarelli, L, Michetti, N, Clissa, C, Ciabattoni, G, Consoli, A & Davì, G 2007, 'Soluble RAGE in type 2 diabetes: Association with oxidative stress', Free Radical Biology and Medicine, vol. 43, no. 4, pp. 511-518. https://doi.org/10.1016/j.freeradbiomed.2007.03.015
Devangelio, Eleonora ; Santilli, Francesca ; Formoso, Gloria ; Ferroni, Patrizia ; Bucciarelli, Loredana ; Michetti, Noemi ; Clissa, Cristina ; Ciabattoni, Giovanni ; Consoli, Agostino ; Davì, Giovanni. / Soluble RAGE in type 2 diabetes : Association with oxidative stress. In: Free Radical Biology and Medicine. 2007 ; Vol. 43, No. 4. pp. 511-518.
@article{af957edabb9e4626b26bfa17f0b5422e,
title = "Soluble RAGE in type 2 diabetes: Association with oxidative stress",
abstract = "Advanced glycation end products (AGEs) contribute to diabetic vascular complications by engaging the AGE receptor (RAGE). A soluble RAGE form (sRAGE) acts as a decoy domain receptor, thus decreasing AGE cellular binding. A cross-sectional comparison of sRAGE, asymmetric dimethylarginine (ADMA) plasma levels (index of endothelial dysfunction), and urinary 8-iso-prostaglandin (PG)F2α (marker of oxidative stress) was performed between 86 diabetic patients and 43 controls. Plasma sRAGE levels were significantly lower and ADMA levels were significantly higher in diabetic patients as compared to controls (P <0.0001). HbA1c and urinary 8-iso-PGF2α were correlated inversely with sRAGE and directly with ADMA. On multivariate analysis HbA1c was independently related to sRAGE levels in diabetic patients. Twenty-four of 86 patients with newly diagnosed diabetes and 12 patients in poor metabolic control were reevaluated after treatment with a hypoglycemic agent or insulin, respectively. Improvement in metabolic control by oral agents or insulin resulted in a significant increase in sRAGE and decrease in ADMA levels (P <0.0001). Thus, poor glycemic control reduces sRAGE levels, in association with enhanced oxidative stress and endothelial dysfunction in diabetes. These abnormalities are susceptible to modulation by improvement in metabolic control.",
keywords = "ADMA, Oxidative stress, RAGE, Type 2 diabetes",
author = "Eleonora Devangelio and Francesca Santilli and Gloria Formoso and Patrizia Ferroni and Loredana Bucciarelli and Noemi Michetti and Cristina Clissa and Giovanni Ciabattoni and Agostino Consoli and Giovanni Dav{\`i}",
year = "2007",
month = "8",
day = "15",
doi = "10.1016/j.freeradbiomed.2007.03.015",
language = "English",
volume = "43",
pages = "511--518",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Soluble RAGE in type 2 diabetes

T2 - Association with oxidative stress

AU - Devangelio, Eleonora

AU - Santilli, Francesca

AU - Formoso, Gloria

AU - Ferroni, Patrizia

AU - Bucciarelli, Loredana

AU - Michetti, Noemi

AU - Clissa, Cristina

AU - Ciabattoni, Giovanni

AU - Consoli, Agostino

AU - Davì, Giovanni

PY - 2007/8/15

Y1 - 2007/8/15

N2 - Advanced glycation end products (AGEs) contribute to diabetic vascular complications by engaging the AGE receptor (RAGE). A soluble RAGE form (sRAGE) acts as a decoy domain receptor, thus decreasing AGE cellular binding. A cross-sectional comparison of sRAGE, asymmetric dimethylarginine (ADMA) plasma levels (index of endothelial dysfunction), and urinary 8-iso-prostaglandin (PG)F2α (marker of oxidative stress) was performed between 86 diabetic patients and 43 controls. Plasma sRAGE levels were significantly lower and ADMA levels were significantly higher in diabetic patients as compared to controls (P <0.0001). HbA1c and urinary 8-iso-PGF2α were correlated inversely with sRAGE and directly with ADMA. On multivariate analysis HbA1c was independently related to sRAGE levels in diabetic patients. Twenty-four of 86 patients with newly diagnosed diabetes and 12 patients in poor metabolic control were reevaluated after treatment with a hypoglycemic agent or insulin, respectively. Improvement in metabolic control by oral agents or insulin resulted in a significant increase in sRAGE and decrease in ADMA levels (P <0.0001). Thus, poor glycemic control reduces sRAGE levels, in association with enhanced oxidative stress and endothelial dysfunction in diabetes. These abnormalities are susceptible to modulation by improvement in metabolic control.

AB - Advanced glycation end products (AGEs) contribute to diabetic vascular complications by engaging the AGE receptor (RAGE). A soluble RAGE form (sRAGE) acts as a decoy domain receptor, thus decreasing AGE cellular binding. A cross-sectional comparison of sRAGE, asymmetric dimethylarginine (ADMA) plasma levels (index of endothelial dysfunction), and urinary 8-iso-prostaglandin (PG)F2α (marker of oxidative stress) was performed between 86 diabetic patients and 43 controls. Plasma sRAGE levels were significantly lower and ADMA levels were significantly higher in diabetic patients as compared to controls (P <0.0001). HbA1c and urinary 8-iso-PGF2α were correlated inversely with sRAGE and directly with ADMA. On multivariate analysis HbA1c was independently related to sRAGE levels in diabetic patients. Twenty-four of 86 patients with newly diagnosed diabetes and 12 patients in poor metabolic control were reevaluated after treatment with a hypoglycemic agent or insulin, respectively. Improvement in metabolic control by oral agents or insulin resulted in a significant increase in sRAGE and decrease in ADMA levels (P <0.0001). Thus, poor glycemic control reduces sRAGE levels, in association with enhanced oxidative stress and endothelial dysfunction in diabetes. These abnormalities are susceptible to modulation by improvement in metabolic control.

KW - ADMA

KW - Oxidative stress

KW - RAGE

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=34447331279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447331279&partnerID=8YFLogxK

U2 - 10.1016/j.freeradbiomed.2007.03.015

DO - 10.1016/j.freeradbiomed.2007.03.015

M3 - Article

C2 - 17640561

AN - SCOPUS:34447331279

VL - 43

SP - 511

EP - 518

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

IS - 4

ER -